![](/img/cover-not-exists.png)
Benefit of Recombinant Human Acid Alpha Glucosidase Treatment (Myozyme) in Late Onset Pompe Disease: About Five Cases Treated for 3 Years
F. Zagnoli, A. Leblanc, C. Blanchard, A. Philippe, M. LastennetVolume:
33
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.clinthera.2011.05.064
File:
PDF, 70 KB
english, 2011